Results 171 to 180 of about 79,325 (265)

Human papilloma virus (HPV) infection associated with cyclosporine-induced gingival overgrowth in renal transplant recipients. [PDF]

J Oral Microbiol
Cossatis JJ, Chicarino de Oliveira Coelho JM, Vasques Novo Martins R, da Silva Lopes G, Baeta Cavalcanti SM, Bonecini-Almeida MDG, Fernandes ATG.   +6 more
europepmc   +1 more source

Incorporating the Competencies of Evidence‐Based Veterinary Medicine Focused on Pharmacotherapeutics Into Clinical Rotations for Small Animal Dermatology and Food Animal Medicine and Surgery at a Veterinary Medical Teaching Hospital in the US

Journal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Building the skills and knowledge necessary to practice evidence‐based veterinary medicine (EBVM) should occur throughout the veterinary curriculum. Operationalizing EBVM includes asking a clinical question in PICO format, searching the biomedical literature for evidence, critically appraising the evidence, and applying the evidence to make a ...
Virginia R. Fajt, Adam P. Patterson, Dusty Nagy, Jennifer Schleining, Kevin Washburn   +4 more
wiley   +1 more source

Eruptive sebaceous hyperplasia induced by oral tacrolimus with good therapeutic response to systemic isotretinoin: a case report. [PDF]

An Bras Dermatol
Silva GPD, Ferreira FR, Moya FG.
europepmc   +1 more source

Growth Assessment in Children Under 12 Years With Moderate‐to‐Severe Atopic Dermatitis Included in the PEDISTAD Observational Registry

Pediatric Dermatology, EarlyView.
ABSTRACT Background/Objective The multifactorial disease burden of moderate‐to‐severe atopic dermatitis (AD) may affect children's growth. We report height, weight, and body mass index (BMI) of children under 12 years old with moderate‐to‐severe AD in comparison to the general population.
Amy S. Paller, Alan D. Irvine, Eulalia Baselga, Marlies de Graaf, Elaine C. Siegfried, Michael J. Cork, Michele Ramien, Lawrence F. Eichenfield, Bryan Adams, Rajan Gupta, Marius Ardeleanu, Annie Zhang   +11 more
wiley   +1 more source

Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Eye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study. [PDF]

Clin Ophthalmol
Johnston J, Adler R, Hessen M, Nichols KK, White D, Saenz B, Bowden Iii F, Periman LM, Truett K, Urbieta M, Mitchell B.   +10 more
europepmc   +1 more source

Orthodontic treatment in periodontitis patients

Periodontology 2000, EarlyView.
Abstract This paper examines the complex interplay between orthodontic intervention and periodontal conditions in individuals with periodontitis. It outlines diagnostic and treatment approaches for adolescents and adults, considering their distinct periodontal, dental, and behavioral needs.
Tali Chackartchi, David Polak, Ayala Stabholz, Stela Chaushu   +3 more
wiley   +1 more source

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy. [PDF]

Ann Hematol
Xing L, Yang W, Fan H, Li J, Zhao Y, Liang W, Shi J, Zhang F, Zhao X.   +8 more
europepmc   +1 more source

Clinical Effectiveness of the Recombinant Zoster Vaccine for Preventing Herpes Zoster in Individuals With Kidney Transplants: A Retrospective Cohort Study

Transplant Infectious Disease, EarlyView.
In this retrospective cohort of kidney transplant recipients, no herpes zoster cases occurred during 398 vaccinated person‐years, compared with 78 cases (16.4 per 1000 person‐years) among unvaccinated recipients. These findings support a protective association of the recombinant zoster vaccine (RZV) and reinforce current recommendations for ...
Kyungsup Kwon, So Yun Lim, Euijin Chang, Seongman Bae, Hyunwook Kwon, Jiwon Jung, Min Jae Kim, Sung Shin, Yong Pil Chong, Young Hoon Kim, Sang‐Ho Choi, Sang‐Oh Lee, Sung‐Han Kim   +12 more
wiley   +1 more source

Current status, development and challenges in the treatment of chronic graft-versus-host disease. [PDF]

Med Rev (2021)
Chen H, Mo X.
europepmc   +1 more source

Impact of Letermovir on Voriconazole Concentrations in Lung Transplant Patients

Transplant Infectious Disease, EarlyView.
Concomitant letermovir was associated with lower voriconazole exposure and reduced attainment of commonly used efficacy thresholds in lung transplant recipients. Routine therapeutic drug monitoring after letermovir initiation is recommended, and empiric voriconazole dose escalation may be needed to avoid subtherapeutic exposure. ABSTRACT Background The
Leah Georgiades, Sunish Shah, Erin K. McCreary, Fernanda Silveira, Raman Venkataramanan, Vignesh Vasudevan, Ryan M. Rivosecchi   +6 more
wiley   +1 more source